In cancer cells, hyperactive PI3K/AKT and mTORC1 signaling increase the expression of rate-limiting enzymes in the PPP (e.g., G6PD and RPIA) via sterol regulatory element-binding protein 1 (SREBP1) activation [22]. Here, AKT1 is linked to cancer.